Streetbeat News

Stock Prices

F

TSLA

Tesla CEO Elon Musk acknowledges that lower-priced EVs from rival automakers are a problem but believes it is a short-term issue. Ford, for example, has been selling its Mustang Mach-E at a lower price than Tesla's Model Y, resulting in significant losses for Ford's EV segment. Tesla plans to introduce more affordable vehicles starting in the first half of 2025.

Portfolio Pulse from Anan Ashraf

August 05, 2024 | 11:12 am

AXSM

Axsome Therapeutics (NASDAQ:AXSM) reported a Q2 2024 adjusted EPS of $(1.12), beating the analyst consensus estimate of $(1.34) by 16.42%.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:12 am

TWKS

Thoughtworks has agreed to be taken private by Apax Funds for $4.40 per share, implying a total enterprise value of $1.75 billion. The purchase price represents a 30% premium to Thoughtworks' closing stock price on August 2, 2024, and a 48% premium over the volume weighted average price for the 30 days ending August 2, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:11 am

BNRG

Brenmiller Energy Ltd. (NASDAQ: BNRG) has entered into a securities purchase agreement with an existing institutional investor to issue 1 million shares at $1.05 per share, raising approximately $1.05 million. The share price reflects a 52% premium to the closing price on August 2, 2024. The investor has the option to purchase an additional 1 million shares if the stock price reaches $2.50 within the next 12 months. The proceeds will be used for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:07 am

BCRX

BioCryst Pharmaceuticals announced its financial outlook, expecting to achieve full-year operating profit in 2024, approach quarterly positive EPS and positive cash flow in the second half of 2025, and be profitable on an EPS basis with positive cash flow for the full year 2026.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:07 am

BCRX

BioCryst Pharmaceuticals has increased its 2024 revenue guidance for Orladeyo to $420M-$435M, up from the previous range of $390M-$400M.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:05 am

SHC

Sotera Health Co has reiterated its FY24 outlook, projecting net revenue growth of 4%-6% and adjusted EPS between $0.67 and $0.75. The company also provided details on interest expenses, tax rates, share count, and capital expenditures.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:05 am

SHC

Sotera Health reported its Q2 2024 financial results, with adjusted EPS of $0.19 beating the estimate of $0.16, and sales of $276.594 million surpassing the expected $266.443 million.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:02 am

K

Kellanova shares are trading higher following a report suggesting Mars is considering an acquisition of the company.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:00 am

BITF

CLSK

COIN

HIVE

MARA

MSTR

RIOT

Shares of crypto-linked stocks are trading lower after Bitcoin fell below $50,000.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 10:59 am